Clinigen Group PLC - ESG Rating & Company Profile powered by AI
Comprehensive ESG analysis of Clinigen Group PLC can be reached by logging in. Other companies in the scoring peer group for Clinigen Group PLC are shownin the table. If you work at Clinigen Group PLC and you would like to licence your ESG aseessment, please contact us.
Clinigen Group PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.7; made up of an environmental score of 0.0, social score of 4.8 and governance score of 3.2.
2.7
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1393 | Vaccinex Inc | 2.8 | Medium |
| 1393 | YSP Southeast Asia Holding Bhd | 2.8 | Medium |
| 1437 | Clinigen Group PLC | 2.7 | Medium |
| 1437 | CanadaBis Capital Inc | 2.7 | Medium |
| 1437 | Cannabics Pharmaceuticals Inc | 2.7 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Clinigen Group PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Clinigen Group PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Clinigen Group PLC report the average age of the workforce?
Sign up for free to unlockDoes Clinigen Group PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Clinigen Group PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Clinigen Group PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Clinigen Group PLC offer flexible work?
Sign up for free to unlockDoes Clinigen Group PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Clinigen Group PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Clinigen Group PLC conduct supply chain audits?
Sign up for free to unlockDoes Clinigen Group PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Clinigen Group PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Clinigen Group PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Clinigen Group PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Clinigen Group PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Clinigen Group PLC disclose water use targets?
Sign up for free to unlockDoes Clinigen Group PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Clinigen Group PLC have a product recall in the last two years?
Sign up for free to unlockDoes Clinigen Group PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Clinigen Group PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Clinigen Group PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Clinigen Group PLC disclose parental leave metrics?
Sign up for free to unlockDoes Clinigen Group PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Clinigen Group PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Clinigen Group PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Clinigen Group PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Clinigen Group PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Clinigen Group PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Clinigen Group PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Clinigen Group PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Clinigen Group PLC disclose its waste policy?
Sign up for free to unlockDoes Clinigen Group PLC report according to TCFD requirements?
Sign up for free to unlockDoes Clinigen Group PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Clinigen Group PLC disclose energy use targets?
Sign up for free to unlockDoes Clinigen Group PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Clinigen Group PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Clinigen Group PLC
These potential risks are based on the size, segment and geographies of the company.
Clinigen Group plc operates as a pharmaceutical and services company in the United Kingdom, rest of Europe, the United States, South Africa, Australia, and internationally. It operates through Services and Products divisions. The company provides a set of niche and high value services to pharma and biotech clients prior to product launch. It also provides access to critical medicines around the world for patients with unmet needs. In addition, the company provides a portfolio of specialist medicines to service the needs of healthcare professionals and their patients in both licensed and unlicensed markets. Further, it offers Nortriptyline Colonis for the treatment of depressive disorder; Metformin Colonis for the treatment of type 2 diabetes mellitus; Magnesium Chewable Tablets, an oral magnesium supplements for the treatment of patients with chronic magnesium loss; Iloprost, a concentrate for solution for infusion; Glycopyrronium Bromide, an oral solution for the treatment of severe sialorrhoea; Acetylcysteine, an oral solution for the treatment of respiratory disorders associated with thick, viscous, and mucus hypersecretion; Cardioxane that protects the heart against the cardiotoxic effects of anthracyclines; Ethyol, which protect against the harmful effects of chemotherapy medications and radiation treatment; Proleukin for the treatment of kidney cancer; Imukin that is used in chronic granulomatous disease; Totect, a dexrazoxane product; Foscavir, an anti-virals that work by stopping viruses from multiplying in number; and Savene, which is indicated in adults for the treatment of anthracycline extravasation. The company was incorporated in 2008 and is headquartered in Burton-on-Trent, the United Kingdom.